- Home
- RLAY vs CTO Comparison
RLAY vs CTO Comparison
Compare RLAY & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- CTO
- Stock Information
- Founded
- RLAY 2015
- CTO 1902
- Country
- RLAY United States
- CTO United States
- Employees
- RLAY N/A
- CTO N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- CTO Real Estate Investment Trusts
- Sector
- RLAY Health Care
- CTO Real Estate
- Exchange
- RLAY Nasdaq
- CTO Nasdaq
- Market Cap
- RLAY 610.3M
- CTO 568.5M
- IPO Year
- RLAY 2020
- CTO N/A
- Fundamental
- Price
- RLAY $3.74
- CTO $17.64
- Analyst Decision
- RLAY Strong Buy
- CTO Strong Buy
- Analyst Count
- RLAY 11
- CTO 3
- Target Price
- RLAY $18.40
- CTO $22.33
- AVG Volume (30 Days)
- RLAY 2.3M
- CTO 313.3K
- Earning Date
- RLAY 08-05-2025
- CTO 07-29-2025
- Dividend Yield
- RLAY N/A
- CTO 8.62%
- EPS Growth
- RLAY N/A
- CTO N/A
- EPS
- RLAY N/A
- CTO N/A
- Revenue
- RLAY $7,679,000.00
- CTO $132,203,000.00
- Revenue This Year
- RLAY $17.59
- CTO $20.11
- Revenue Next Year
- RLAY N/A
- CTO $8.51
- P/E Ratio
- RLAY N/A
- CTO N/A
- Revenue Growth
- RLAY N/A
- CTO 17.48
- 52 Week Low
- RLAY $1.78
- CTO $16.12
- 52 Week High
- RLAY $10.72
- CTO $21.15
- Technical
- Relative Strength Index (RSI)
- RLAY 58.29
- CTO 50.37
- Support Level
- RLAY $3.47
- CTO $17.50
- Resistance Level
- RLAY $3.97
- CTO $17.77
- Average True Range (ATR)
- RLAY 0.20
- CTO 0.31
- MACD
- RLAY -0.00
- CTO 0.06
- Stochastic Oscillator
- RLAY 54.00
- CTO 78.36
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a real estate investment trust company, that owns income properties comprised of approximately 2.7 million square feet in diversified markets in the United States. Its portfolio of assets consists of Income Properties Portfolio, management services, Commercial Loan and Investments.